openPR Logo
Press release

Meningitis Diagnosis & Treatment Market Comprehensive Analysis and Future Estimation with Top Companies: Thermo Fisher Scientific, Inc., Fast Track Diagnostics Ltd, Siemens Healthineers, Bio-Rad Laboratories, IMMY, Seegene Inc

03-26-2019 08:19 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Meningitis Diagnostic and Treatment Market

Meningitis Diagnostic and Treatment Market

The Meningitis Diagnosis and Treatment Market size is anticipated to reach over USD 157.8 million by 2026. In 2017, the bacterial type dominated the global market, in terms of revenue. Asia-Pacific is expected to be the fastest growing contributor to the global market revenue in 2017.

Swelling to the meninges is known as meningitis. Meningitis affects the meninges, the membranes that covers spinal cord and brain that protect the central nervous system (CNS) along with the cerebrospinal fluid. Meningitis can cause by bacteria, fungal and virus. Bacterial infection is the most common meningitis. Some of the bacteria that can cause bacterial meningitis are Group B Streptococcus and Streptococcus pneumoniae (S. pneumoniae). Other types of meningitis are non-infectious meningitis, viral, parasitic, and fungal. However, the bacterial type is the most lethal which is considered as life-threatening type.

Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnosis-treatment-market/request-for-sample?utm_source=openpr.com&utm_medium=referral&utm_campaign=shivani_Mar26_meningitis-diagnosis-treatment/smpl&utm_content=Content

Other factors causing meningitis are HIV, tuberculosis, and certain illness. According to the World Health Organization (WHO), Human Immunodeficiency Virus (HIV) is major infectious disease. According to the same reports, around 36.7 million people across the globe were living with HIV during 2017. Such high prevalence of transferable illnesses is expected to drive the demand for diagnostic tests. Meningitis diagnostic test are carried out on human samples in order to prevent meningitis and/or diagnose meningitis and regulate drug therapies.

The growing investments on the R&D for efficient diagnosis and the treatment of such critical disease and rising occurrence of meningitis cases are the major factors estimated to boost the growth of the market. In addition, development of new technologies as well as devices and continuous growth of the medical device sector are other factors driving the market growth. However, strict regulatory guidelines and unawareness regarding the treatments and diagnosis are estimated to hamper the market growth.

The industry is segmented on the basis of type, diagnostic test, end user, and geography. Based on type, the market is bacterial, viral and fungal. on the basis of diagnostic tests, the market is segmented into PCR Assay, Lateral Flow Assay, Latex Agglutination Tests, ELISA Tests, and Culture Test. By end user, the market is further bifurcated as hospitals, diagnostic centers and others.

Make Inquiry about this report @ https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnosis-treatment-market/inquire-before-buying?utm_source=openpr.com&utm_medium=referral&utm_campaign=shivani_Mar26_meningitis-diagnosis-treatment/inquir&utm_content=Content

The market for meningitis diagnosis and treatment in North America generated the highest revenue in 2017, and is expected to be the leading region globally during the forecast period. Availability of technologically advanced devices as well as high adoption rate for such diagnosis devices, and the increasing investment on early diagnosis of diseases are major factors associated with the high market share in the region. Additionally, upsurge in the awareness regarding several brain disease including meningitis among the patients estimated to bolster the market growth in North America.

Asia Pacific is estimated to be the fastest growing region in terms of revenue. High occurrence of people suffering from meningitis along with increasing focus early diagnosis and treatment for the disease, provides significant growth opportunities of the market in APAC
.
The major key players operating in the meningitis diagnosis and treatment industry include Thermo Fisher Scientific, Inc., Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers, Bio-Rad Laboratories, Inc., IMMY, BioFire Diagnostics, Nanosphere (Luminex Corporation), Seegene Inc., Qnostics, ELITechGroup, and Abbott Laboratories. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Check for discount: https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnosis-treatment-market/request-for-discount-pricing?utm_source=openpr.com&utm_medium=referral&utm_campaign=shivani_Mar26_meningitis-diagnosis-treatment/dscnt&utm_content=Content

Polaris Market Research has segmented the global Meningitis Diagnosis and Treatment Market on the basis of type, diagnostic test, end user and region:

Meningitis Diagnosis and Treatment by Type Outlook (Revenue, USD Million, 2015 – 2026)
• Bacterial
• Fungal
• Viral

Meningitis Diagnosis and Treatment by Diagnostic Test Outlook (Revenue, USD Million, 2015 – 2026)
• PCR Assay
• Lateral Flow Assay
• Latex Agglutination Tests
• ELISA Tests
• Culture Test

Meningitis Diagnosis and Treatment by End-User Outlook (Revenue, USD Million, 2015 – 2026)
• Hospitals
• Diagnostic Centers
• Others

Meningitis Diagnosis and Treatment Regional Outlook (Revenue, USD Million, 2015 – 2026)
• North America
• U. S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Belgium
• Russia
• Netherlands
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Korea
• Singapore
• Malaysia
• Indonesia
• Thailand
• Philippines
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of LATAM
• Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA

Browse for full research summary : https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnosis-treatment-market/?utm_source=openpr.com&utm_medium=referral&utm_campaign=shivani_Mar26_/meningitis-diagnosis-treatment/RD&utm_content=Content

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.

Contact us-

Mr. Rohit
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Meningitis Diagnosis & Treatment Market Comprehensive Analysis and Future Estimation with Top Companies: Thermo Fisher Scientific, Inc., Fast Track Diagnostics Ltd, Siemens Healthineers, Bio-Rad Laboratories, IMMY, Seegene Inc here

News-ID: 1671353 • Views:

More Releases from Polaris Market Research & Consulting

Last Mile Delivery Market Valued US$ 297.57 Billion and Expected to Register 8.60% CAGR by 2032 | PMR
Last Mile Delivery Market Valued US$ 297.57 Billion and Expected to Register 8.6 …
According to Polaris Market Research's latest study, "Last Mile Delivery Market by Service Type (B2C, B2B, C2C); Technology (Autonomous, Non-Autonomous); Application; Region, And Segment Forecasts, 2024 - 2032," the market for last mile delivery was valued at USD 142.21 billion in 2023. It is anticipated to grow to USD 297.57 billion by 2032 and exhibit a compound annual growth rate of 8.60% during the forecast period from 2024 to 2032. 𝐄𝐱𝐩𝐥𝐨𝐫𝐞
Terminal Tractor Market Valued US$ 1,245.08 Million and Expected to Register 4.60% CAGR by 2032 | PMR
Terminal Tractor Market Valued US$ 1,245.08 Million and Expected to Register 4.6 …
Polaris Market Research has added the latest Report on the Terminal Tractor Market. The report primarily includes share, size, demand, growth factors, revenue, and analysis of global companies. The global market was valued at USD 835.67 Million in 2023 and is expected to grow to USD 1,245.08 Million by 2032 at a CAGR of 4.60% during the forecast period. 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/industry-analysis/terminal-tractor-market/request-for-sample 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧 A terminal tractor, sometimes called
Coronary Stent Market is expected to reach US$ 12,248.80 Million by 2032, at a CAGR of 4.40 from 2024 to 2032 | PMR
Coronary Stent Market is expected to reach US$ 12,248.80 Million by 2032, at a C …
According to Polaris Market Research's study, the Coronary Stent Market is expected to grow at a CAGR of 4.40% over the estimated period. The industry value is expected to grow from USD 8306.55 million in 2023 to USD 12,248.80 million in 2032. The industry's growth is being fuelled by the growing pervasiveness of coronary heart disorders globally. Also, the market for coronary stents is expanding because clinical trials are being
Public Key Infrastructure (PKI) Market Sets New Record, Projected at USD 19657.5 Million By 2032 at 20.6% CAGR
Public Key Infrastructure (PKI) Market Sets New Record, Projected at USD 19657.5 …
The public key infrastructure (PKI) market size is projected to be valued at USD 3032.9 million in 2023 and is expected to rise to USD 19657.5 million by 2032. The market is expected to register a CAGR of 20.6% during the forecast period. Various factors propelling the demand for PKI include: ● The public key infrastructure (PKI) industry is expanding due to notable innovation in the business and corporate sectors, which supports

All 5 Releases


More Releases for Meningitis

Meningitis - Drug Pipeline Landscape, 2022 | Global Insight Services
Meningitis is an inflammation of the fluid and membranes (meninges) surrounding your brain and spinal cord. Meningitis can be caused by a bacterial, fungal or viral infection. Viral infections are the most common cause of meningitis, followed by bacterial infections and, rarely, fungal and parasitic infections. Less common causes of meningitis include autoimmune disorder, cancer medicines. Meningitis symptoms include confusion, fever, headache numbness, sensitivity to light, stiff neck, upset stomach
Meningitis Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Meningitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Meningitis, historical and forecasted epidemiology as well as the Meningitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Meningitis market report provides current treatment practices, emerging drugs, Meningitis market share of the individual therapies, and current and forecasted Meningitis market size from 2019 to 2032 segmented by
United States Meningitis Vaccine Market Report
In this report, the United States Meningitis Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share
Global Meningitis Vaccine Market Analysis |Outlook to 2025
This report at InForGrowth presents the worldwide Meningitis Vaccine market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. Download for Sample copy of this report at https://www.inforgrowth.com/samplerequest/r/16184/global-meningitis-vaccine-market-insights-fore The
Meningitis Vaccine Market Report 2018: Segmentation by Product (Meningitis A+C, …
Global Meningitis Vaccine market research report provides company profile for Pfizer, Zhejiang Tianyuan, Beijing Tiantan Biological, Baxter International, Sanofi Pasteur, Merck and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides
Advancements in Meningitis Vaccine to Foster the Growth of Meningitis Vaccine Ma …
“Meningitis Vaccine Market: Global Demand, Growth Analysis & Opportunity Outlook 2023” The global meningitis vaccine market is segmented into vaccines such as polysaccharide vaccines, conjugate vaccines and combination vaccines. Among these segments, combination vaccine is expected to grow at highest CAGR in overall meningitis vaccine market during the forecast period. Increasing utilization of combination vaccines for the prevention of disease in infants is the major factor behind the growth of combination